drugset / Trial / NCT00002371
The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine
RandomizedParallel-groupDouble-blindTreatment
Summary
To compare the magnitude and durability of the reduction in plasma HIV RNA in the two treatment groups over the first 12 weeks of treatment. To determine the safety of each of the two treatment groups.
Timeline
- Start
- 1996-06
- Primary completion
- 1997-12
- Completion
- 1997-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Stavudine | Other / unclassified | — | — |
| Subject | Zidovudine | Small molecule | — | — |
| Background | INDINAVIR ANHYDROUS | Other / unclassified | — | — |
| Background | Lamivudine | Other / unclassified | — | — |